Britannia Life Sciences Inc.

C$0.07As of Sun 8 Nov 2026, 12:00 UTC
CSE:BLABHealthcare
Country Canada
PE (Fwd) •••
TSR 5Y CAGR (18.73%)
Div yield —
ROE 108.44%
Biotechnology
Beta (5Y) 0.01
PE TTM 0.687
TSR TTM (36.36%)
Mkt cap C$11.52M
ROIC (20.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.084
20.01%
(54.75%)
Hold 8|10|1|0|0
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
(0.36%)
(0.14%)
8.06%
14.77%
Revenue$M
1.075
1.078
1.057
1.069
2.72%
4.39%
(0.44%)
(1.88%)
Peers (US$8.155M)
Cap (US$)
PE
7.483M
—
7.338M
—
Capital
TTM
5Y
10Y
Leveragex
0.744
(0.027)
(0.026)
EBIT/Intx
1.453
0.653
0.586
Own earn%
66.51
16.59
28.58
Sh yield%
36.95
32.70
38.15
Owners
Insiders/Inst%
10.19
25.44
Short interest%
3.35
SBC / revenue%
4.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
22–29
$1 testx
—
Incr. ROIC%
11